Granules India is currently trading at Rs 93.70, up by 3.75 points or 4.17% from its previous closing of Rs. 89.95 on the BSE.
The scrip opened at Rs. 90.60 and has touched a high and low of Rs 93.95 and Rs. 90.60 respectively. So far 918527 shares were traded on the counter.
The BSE group 'B' stock of face value Rs. 1 has touched a 52 week high of Rs. 104.00 on 15-Apr-2015 and a 52 week low of Rs. 54.27 on 15-Jul-2014.
Last one week high and low of the scrip stood at Rs. 93.95 and Rs. 80.05 respectively. The current market cap of the company is Rs. 1878.69 crore.
The promoters holding in the company stood at 48.59% while Institutions and Non-Institutions held 4.11% and 47.30% respectively.
Granules India is planning to focus on Research and Development (R&D) and formulations. Moreover, the company may look at acquiring companies having high technology in formulations manufacturing or with a sizable formulations portfolio. The company would like to make 1-2 acquisitions preferably in the US and in India if it could find a right company.
Granules India is a fast growing pharmaceutical manufacturing company with world class facilities and is committed to manufacturing excellence, quality and customer service. The Company produces Finished Dosages (FDs), Pharmaceutical Formulation Intermediates (PFIs) and Active Pharmaceutical Ingredients (APIs) for quality conscious customers in the regulated and semi-regulated markets.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1786.05 |
Dr. Reddys Lab | 1354.20 |
Cipla | 1470.05 |
Lupin | 2190.50 |
Zydus Lifesciences | 1004.05 |
View more.. |